Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure.

Ahmad T, Patel CB, Milano CA, Rogers JG.

Circulation. 2012 Jun 12;125(23):2948-55. doi: 10.1161/CIRCULATIONAHA.112.097337. No abstract available.

2.

Letter by Rosner et al regarding article, "When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure".

Rosner GF, Garan AR, Uriel N.

Circulation. 2013 Jan 29;127(4):e431. doi: 10.1161/CIRCULATIONAHA.112.127589. No abstract available.

3.

Current medical therapy for advanced heart failure.

Gheorghiade M, Cody RJ, Francis GS, McKenna WJ, Young JB, Bonow RO.

Heart Lung. 2000 Jan-Feb;29(1):16-32. Review. No abstract available.

PMID:
10636954
4.

Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone.

Earl GL, Verbos-Kazanas MA, Fitzpatrick JM, Narula J.

Pharmacotherapy. 2007 May;27(5):697-706.

PMID:
17461705
5.

[Options in drug combinations].

Correia JM.

Rev Port Cardiol. 2001 Mar;20 Suppl 3:39-49. Portuguese.

PMID:
11409073
6.

Effects of beta-blocker therapy in severe chronic heart failure.

Negut C.

N Engl J Med. 2001 Sep 27;345(13):998; author reply 998-9. No abstract available.

PMID:
11575300
7.

Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failure.

Demopoulos L, Yeh M, Gentilucci M, Testa M, Bijou R, Katz SD, Mancini D, Jones M, LeJemtel TH.

Circulation. 1997 Apr 1;95(7):1764-7.

8.

Could beta-blockers precede or replace angiotensin-converting enzyme inhibitors in heart failure?

Remme WJ.

Heart Fail Clin. 2005 Apr;1(1):67-75. Review. No abstract available.

PMID:
17386835
9.

Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.

McMurray J, Cohen-Solal A, Dietz R, Eichhorn E, Erhardt L, Hobbs FD, Krum H, Maggioni A, McKelvie RS, Piña IL, Soler-Soler J, Swedberg K.

Eur J Heart Fail. 2005 Aug;7(5):710-21.

11.

Digitalis for treatment of congestive heart failure in patients in sinus rhythm.

Cayley WE Jr.

Am Fam Physician. 2004 Jan 1;69(1):71-2. No abstract available.

12.

[Prevention and treatment of congestive heart failure in diabetic patients].

Anguita Sánchez M.

Rev Esp Cardiol. 2002 Oct;55(10):1083-7. Review. Spanish.

14.

Improving care of chronic heart failure: advances from drugs to devices.

Starling RC.

Cleve Clin J Med. 2003 Feb;70(2):141-6.

PMID:
12636345
16.

Are beta-blockers needed in patients receiving spironolactone for severe chronic heart failure? An analysis of the COPERNICUS study.

Krum H, Mohacsi P, Katus HA, Tendera M, Rouleau JL, Fowler MB, Coats AJ, Roecker EB, Packer M; Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group.

Am Heart J. 2006 Jan;151(1):55-61.

PMID:
16368292
17.

Effects of beta-blocker therapy in severe chronic heart failure.

Sabio JM, Jiménez-Alonso J.

N Engl J Med. 2001 Sep 27;345(13):998-9. No abstract available.

18.

Systems and diseases. The heart, Part Ten. Heart failure-2.

Gordon K, Child A.

Nurs Times. 2000 Apr 20-26;96(16):49-52. No abstract available.

PMID:
11309947
19.

Cost-effectiveness of beta-blocker therapy with metoprolol or with carvedilol for treatment of heart failure in Canada.

Levy AR, Briggs AH, Demers C, O'Brien BJ.

Am Heart J. 2001 Sep;142(3):537-43.

PMID:
11526370
20.

Case studies in heart failure.

Paul S, Trupp RJ.

Crit Care Nurs Clin North Am. 2003 Dec;15(4):519-23, x.

PMID:
14717398

Supplemental Content

Support Center